Next Article in Journal
Inter-Institutional Pathology Consultations for Breast Cancer: Impact on Clinical Oncology Therapy Recommendations
Previous Article in Journal
Cost-Effectiveness of Oxaliplatin in the Adjuvant Treatment of Colon Cancer in Canada
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Pathology Re-Review as an Essential Component of Breast Cancer Management

Department of Pathology, University of Michigan Medical School, 4217 Comprehensive Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA
Curr. Oncol. 2010, 17(1), 2-3; https://doi.org/10.3747/co.v17i1.517
Submission received: 7 November 2009 / Revised: 4 December 2009 / Accepted: 9 January 2010 / Published: 1 February 2010

Abstract

Approximately one third of cancers in women arise in the breast, making breast cancer the most commonly diagnosed cancer by far [...]

Share and Cite

MDPI and ACS Style

Kleer, C.G. Pathology Re-Review as an Essential Component of Breast Cancer Management. Curr. Oncol. 2010, 17, 2-3. https://doi.org/10.3747/co.v17i1.517

AMA Style

Kleer CG. Pathology Re-Review as an Essential Component of Breast Cancer Management. Current Oncology. 2010; 17(1):2-3. https://doi.org/10.3747/co.v17i1.517

Chicago/Turabian Style

Kleer, Celina G. 2010. "Pathology Re-Review as an Essential Component of Breast Cancer Management" Current Oncology 17, no. 1: 2-3. https://doi.org/10.3747/co.v17i1.517

APA Style

Kleer, C. G. (2010). Pathology Re-Review as an Essential Component of Breast Cancer Management. Current Oncology, 17(1), 2-3. https://doi.org/10.3747/co.v17i1.517

Article Metrics

Back to TopTop